首页 | 本学科首页   官方微博 | 高级检索  
     

青春期多囊性卵巢综合征的病因和治疗初探
引用本文:尹潍,马通军,朱楣光,韩玉昆,石萍. 青春期多囊性卵巢综合征的病因和治疗初探[J]. 天津医药, 2003, 31(1): 17-19
作者姓名:尹潍  马通军  朱楣光  韩玉昆  石萍
作者单位:1. 300052,天津医科大学总医院
2. 天津市中心妇产科医院
摘    要:目的:探讨青春期多囊性卵巢综合征(PCOS)患者血清胰岛素(sINS)及睾酮(sT)升高的关系和治疗。方法:对10例肥胖、多毛、闭经已1~4年诊为PCOS的15~19岁少女,检测体重指数(BMI)、sINS、sT、OGTT、馒头耐量试验(OBTT)、胰岛素敏感指数的自然对数(ISI LN)。用α糖苷酶抑制剂-拜唐苹(Acarbose)治疗,其中4例合用二甲双胍。结果:与对照组及治疗前后比较:治疗后体重、BMI显著下降。治疗前后各项测值分别为:sT(46.51±7.57)pmol/L和(16.70±6.75)pmol/L;2h馒头耐量试验测值,曲线下INS面积分别为(408.81±222.57)mU/L和(95.08±20.41)mU/L(P<0.01);INI由-7.5±0.6升到-5.6±0.6获得显著改善(P<0.01)。7例恢复自发月经,其中3例显示已排卵3次以上,2例分别停药20和26个月,仍然规律地行经。3例启动自发月经失败。结论:α糖苷酶抑制剂或(和)二甲双胍可降低血糖,改善INS抵抗,sINS水平下降伴sT正常有利于改善垂体卵巢轴的功能。治疗期中未见明显毒副作用。

关 键 词:青春期 病因 治疗 多囊卵巢综合征 胰岛素 睾酮 二甲双胍 拜唐苹

Etiology and Treatment of Polycystic Ovary Syndrome in Adolescent Girls
YIN Wei,MA Tongjun.ZHU Meiguang.HAN Yukun.SHI Ping. Etiology and Treatment of Polycystic Ovary Syndrome in Adolescent Girls[J]. Tianjin Medical Journal, 2003, 31(1): 17-19
Authors:YIN Wei  MA Tongjun.ZHU Meiguang.HAN Yukun.SHI Ping
Affiliation:YIN Wei,MA Tongjun.ZHU Meiguang.HAN Yukun.SHI Ping Department of Endocrinology,Tianjin Medical University Hospital,Tianjin 300052,China
Abstract:Objective:To investigate the etiology and treatment of polycystic ovary syndrome(PCOS)in adolescent girls.Methods: Ten girls with PCOS aged 15-19 years served as a treatment group, while 10 healthy girls served as a control group. They were examined by BMI, sINS, sT, OGTT, OB(bread)TT and ISI LN. All patients were treated with acarbose(a glucosidose inhibitor) for 5-31 monthes, and metforin was added in 4 patients. Results: After treatment, the sT level decreased from(46. 51 + 7. 57)pmol/L to (16. 70 + 6.75)pmol/L, the sum of OB(bread)TT 0-2 h: INS square decreased from(408.81 + 222. 57)mU/L to (95.08+ 20.41)mU/L and the INI LN level increased from-7.5+0.6 to-5.6+0.6(all P<0.01) .After treatment, regulatory menstrual cycles recovered in 7 patients, among whom drugs were sloped for 20 or 26 monthes in 2 patients. This cycle failed to recover in 3 patients.Conclusion: The glucosidose inhibitor and/or metforin may decrease circulating glucose and ISN levels and improve ovarian function.
Keywords:polycystic ovary syndrome insulin testosterone metformin acarbose
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号